Publications Search

Search for publications by author
Search for publications by abstract keyword(s)

Novel application of luciferase assay for the in vitro functional assessment of KAL1 variants in three females with septo-optic dysplasia (SOD)


KAL1 is implicated in 5% of Kallmann syndrome cases, a disorder which genotypically overlaps with septo-optic dysplasia (SOD). To date, a reporter-based assay to assess the functional consequences of KAL1 mutations is lacking. We aimed to develop a luciferase assay for novel application to functional assessment of rare KAL1 mutations detected in a screen of 422 patients with SOD. Quantitative analysis was performed using L6-myoblasts stably expressing FGFR1, transfected with a luciferase-reporter vector containing elements of the FGF-responsive osteocalcin promoter. The two variants assayed [p.K185N, p.P291T], were detected in three females with SOD (presenting with optic nerve hypoplasia, midline and pituitary defects). Our novel assay revealed significant decreases in transcriptional activity [p.K185N: 21% (p < 0.01); p.P291T: 40% (p < 0.001)]. Our luciferase-reporter assay, developed for assessment of KAL1 mutations, determined that two variants in females with hypopituitarism/SOD are loss-of-function; demonstrating that this assay is suitable for quantitative assessment of mutations in this gene.

Type Journal
ISBN 1872-8057 (Electronic) 0303-7207 (Linking)
Authors McCabe, M. J. ; Hu, Y. ; Gregory, L. C. ; Gaston-Massuet, C. ; Alatzoglou, K. S. ; Saldanha, J. W. ; Gualtieri, A. ; Thankamony, A. ; Hughes, I. ; Townshend, S. ; Martinez-Barbera, J. P. ; Bouloux, P. M. ; Dattani, M. T.;
Responsible Garvan Author (missing name)
Published Date 2015-01-01
Published Volume 417
Published Pages 63-72
Status Published in-print
URL link to publisher's version
OpenAccess link to author's accepted manuscript version